The Biotech Journey:
From Inception to Exit
Get an inside look at how Tusk Therapeutics found the right partners at Roche, negotiated an acquisition, and then spun out as Black Belt Tx, from Robert de Jonge, former Head of Business Development at Tusk Therapeutics and current CEO of Black Belt Tx.
- Build an effective company strategy,
- Pitch to investors and leverage value inflection points successfully,
- Transition smoothly through the acquisition & spin-out process.
Please complete the form below
All fields marked with a * are required.
Our cloud-based solutions help life science companies manage
their biopharma opportunities more efficiently. They find all their
partnering information in one place, track their deals and alliances
easily and report on their pipeline and activities in seconds.
the 20 biggest biopharma events automatically available in Inova,
providing our users with always up-to-date company and contact
information. Over 130 life science companies, including 50% of the
top 50 pharmaceutical companies and many midsize pharma and
innovative biotechs already use Inova.